BTK Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach 

Co-Chairs, Benjamin M. Greenberg, MD, MHS and Professor Anthony Traboulsee, MD, discuss multiple sclerosis in this CME/NCPD/CPE activity titled “Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach.” For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/CPE information, and to apply for credit, please visit us at PeerView.com/NXB865. CME/NCPD/CPE credit will be available until November 27, 2022.